Metformin Pharmacogenomics: Current Status and Future Directions
The incidence of type 2 diabetes (T2D) and its costs to the health care system continue to rise. Despite the availability of at least 10 drug classes for the treatment of T2D, metformin remains the most widely used first-line pharmacotherapy for its treatment; however, marked interindividual variabi...
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
American Diabetes Association
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113063/ |